2-Methyl-2-Adamantanol - Manufacturers, Suppliers, Factory from China

2-Methyl-2-Adamantanol, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

2-Methyl-2-Adamantanol CAS 702-98-7 Purity 99.0 (GC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 2-Methyl-2-Adamantanol CAS 702-98-7 Purity >99.0% (GC)
Read More

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

Related Blog
Reviews

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...

2022.10.22 23:35:53
2022.10.01 20:36:09
2022.09.19 07:20:31
2022.08.25 13:47:13
2022.07.15 23:14:34
2021.12.25 10:09:47

2-Methyl-2-Adamantanol - Manufacturers, Suppliers, Factory from China

Related Products

2-Methyl-2-Adamantanol CAS 702-98-7 Purity >99.0% (GC)

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

Naltrexone Hydrochloride CAS 16676-29-2 API USP Standard High Purity

Phenethyl Phenylacetate CAS 102-20-5 Purity >98.0% (GC) Manufacturer

Boc-Lys(2-Cl-Z)-OH CAS 54613-99-9 Purity >99.0% (HPLC) Factory

Boc-Pro-OSu CAS 3392-10-7 Boc-L-Proline N-Hydroxysuccinimide Ester Purity >99.0% (HPLC)

Boc-D-Arg-OH·HCl·H2O CAS 114622-81-0 Purity >99.0% (HPLC)

Acetobromo-α-D-Glucuronic Acid Methyl Ester CAS 21085-72-3 Assay >95.0% (HPLC)

Furosemide CAS 54-31-9 Assay ≥99.0% Diuretic API Factory High Quality

Fmoc-Cha-OH CAS 135673-97-1 Purity >98.0% (HPLC)

2,5-Dimethyl-2,5-Hexanediol CAS 110-03-2 Purity >99.5% (GC)

3-Methylpyridazine CAS 1632-76-4 Purity >98.5% (GC) Factory

Imidazole CAS 288-32-4 Purity ≥99.5% (GC) Factory Main Product

4-(3-Chloropropyl)morpholine CAS 7357-67-7 Gefitinib Intermediate Purity >98.0% (GC)

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The “Summit on COVID-19 Diagnostics & Treatment”

New COVID treatments offer hope

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

Paxlovid: what we know about Pfizer's Covid-19 pill

2022.10.22 23:35:53

2022.10.01 20:36:09

2022.09.19 07:20:31

2022.08.25 13:47:13

2022.07.15 23:14:34

2021.12.25 10:09:47

related search